Pharmaceutical Executive-01-01-2013

Pharmaceutical Executive

Industry Forecast 2013

January 25, 2013

Features

0

0

As companies seek safety from empowered payers, bankrupt governments, and distracted regulators, success will come to those who understand how competition and technology are changing the way everything this industry does.

Country Report: Singapore

January 01, 2013

Country Report

0

0

Most executives across the pharmaceutical industry agree-Singapore does not represent any question marks in the future. Furthermore, Singapore's location is ideal for reaching markets east, west, north and south, which form the powerhouse that is Asia-Pacific.

Compliance in the C-Suite

January 01, 2013

Features

0

0

Compliance officers have risen into management's highest ranks, by choice in some organizations, and by government decree in others. Either way, their importance as a strategic partner can hardly be understated.

The Long Swim—Upstream

January 01, 2013

From the Editor

0

0

2013 may be a number associated with the fate of the luckless, but our annual review of the business and policy environment for Big Pharma suggests otherwise-as we near the midway point in the "tween" decade, there is good fortune in store for those with the perspective that comes with the long view.

The Permanent Campaign

January 01, 2013

Features

0

0

Promoting the merits of private-sector drug innovation is no easy task-just ask the UK's Office of Health Economics, with a record 50 years of engagement around the hard policy questions that ultimately drive success in the pharmaceutical marketplace.

Pharmaceutical Executive Digital Edition - January 2013

January 01, 2013

Issue PDF

0

0

Industry Forecast 2013, The Search for Safe Harbors